Methodist Hospitals introduces MRI-compatible implantable cardioverter defibrillator to Northwest Indiana - February 3, 2016

Courtesy of The Chicago Tribune

February 3, 2016

Methodist Hospitals is breaking new ground in cardiovascular in Northwest Indiana.

It is the first hospital to offer patients an implantable cardioverter defibrillator (ICD) system that is safe for use with magnetic resonance imaging (MRI).

Recently approved by the FDA, the Medtronic Evera MRI™ SureScan® ICD is a breakthrough device that fills a critically unmet need.

An ICD delivers a lifesaving shock or painless pacing to stop life-threatening rapid or irregular heartbeats. They are prescribed to continuously monitor heart rate and correct irregularities in at-risk patients. Patients who benefit from an ICD include those who have dangerously rapid or irregular heartbeats, have survived an episode of a sudden cardiac arrest, or who have suffered a heart attack and have impaired function in the lower chambers of the heart.

The ICD is a small device, usually implanted beneath the skin on the left side of the chest just below the collarbone. The procedure is minimally invasive and takes about one hour, and is sometimes performed on an outpatient basis

ICDs have been saving lives for more than 30 years and are proven to be 98 percent effective. Today’s ICDs are highly sophisticated and deliver impulses only when needed.

Until recently, patients who were fitted with an ICD had to forgo having MRI scans due to potential interactions between the MRI and the device function. This prevented many of the patients who most needed the advanced diagnostic capabilities of an MRI from receiving one.

“An MRI can show things that CAT scans and other tests don’t show,” explains Methodist Hospitals cardiologist Dr. Harish Shah.

“Patients with ICDs are often older adults with other serious medical conditions that require an MRI for diagnosis,” says Dr. Andre Artis, cardiologist and medical director of the Heath and Vascular Institute at Methodist Hospitals. “MRIs are commonly used to diagnose many conditions including stroke, cancer, Alzheimer’s disease, and muscle, bone and back pain. Data have shown that more than one-third of patients with ICDs are likely to need an MRI.

The Medtronic Evera MRI™ SureScan® ICD is the first device of its kind approved by the FDA for use with MRI scans on any part of the body, including full body scans. Tests show this device to be 100 percent free from MRI-related complications.

“This new device should become the standard of care,” says Methodist Hospitals cardiologist Dr. Sorin Lazar.